Luye Pharma Switzerland

Luye Pharma Group

Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and the EU, with a robust pipeline of 30 drug candidates in China and more than 10 drug candidates overseas. The company currently has a number of new drugs and new formulations in the central nervous system and oncology therapeutic areas under study in the U.S. and the EU. Luye Pharma is a global cutting edge company in terms of research into new drug delivery technologies, such as microspheres, liposomes and transdermal drug delivery systems. The company is forward looking, with strategic development of innovative new compounds and antibodies, gene & cell therapies and smart formulations.

Luye Pharma has set up 7 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. The company offers more than 30 products covering the 4 largest and fastest growing therapeutic areas — oncology, cardiovascular, metabolism and central nervous system, with business conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets - China, the U.S., the EU and Japan, as well as fast growing emerging markets.

Mr Gilbert Pfund
Senior Manager Business Development and Licensing 

Luye Supply AG Switzerland

Dr Bruno Delie
Dr Bruno Delie
General Manager 

Max Zeller Söhne AG Switzerland

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.


Dr Si Chen
Dr Si Chen
LinkedIn logo Business Development Manager 
Ms Yulia Kirschner
Ms Yulia Kirschner
LinkedIn logo Director International Division 

Medinova AG Switzerland

Mr Frank Buennig
Managing Director 

Medis d.o.o. Slovenia

Medis doo is the leading commercialization partner for innovative companies in the CSEE region. With 29 years of experience, we have proven our capabilities and reliability to many most admired pharmaceutical/biotech companies. We have the highest financial rating, 300+ employees and strong presence in hospital and retail.

Medis is looking for new cutting-edge medical solutions, to address unmet medical needs in the CSEE.

Anja Bervar
LinkedIn logo Head of Business Development 

MergerMotives Switzerland

MergerMotives GmbH - The M&A Consulting Boutique

"Customized support for Mergers & Acquisitions, In- and Outlicensing, Business Development and other related areas".

We are a small and specialized M&A consulting boutique with a young and innovative mindset that is advising and supporting its clients in Mergers & Acquisitions, In- and Outlicensing, Business Succession, Business Development and other related areas. Our clients are companies from various industries all around the world that either do not have their own Business Development team or that need some additional temporary resources for their M&A team.

Mr Adrian Pflugshaupt
Mr Adrian Pflugshaupt
LinkedIn logo Managing Partner 

Mike Parnell Associates United Kingdom

Mr Mike Parnell
Principal Consultant 

Mitsubishi Tanabe Pharma Europe Ltd United Kingdom

Dr Amarjit Reahal
GM EU Operations 

Mundipharma Spain

Mundipharma is a global, independent network empowered locally.

We are an asset led, privately owned business, with international presence and in-depth knowledge of the local market.

Our network of independent affiliated companies enables us to leverage our integrated capabilities from discovery to product commercialization.

Built on a tradition of entrepreneurship, our flexibility and way of doing things have allowed us to forge a solid and trustful relationship with our partners, ensuring the sustained success of our business.

Focused on delivering commercial excellence, we actively evaluate opportunities to complement our existing product portfolio, to substantially improve patient’s quality of life.

Dr Jose Millan
Dr Jose Millan
LinkedIn logo Southern European Strategy and Business Development Head 

Mylan France

Mrs Magali Pernot
Portfolio Director France